Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Acinetobacter

ABSTRACT: Surveillance of carbapenem resistant Acinetobacter spp.

PROVIDER: PRJNA602201 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR10916012.fastq.gz	Fastqsanger.gz
	SRR10916013.fastq.gz	Fastqsanger.gz

Items per page:

1 - 3 of 3

Similar Datasets

Characterization functional of AcoN-like negative regulator protein from Acetoin cluster in Acinetobacter spp. Strains

Project description:Studies of expression of mechanims of defense of the Acinetobacter sp.5-2Ac.02 from airborne hospital environment under stress conditions, such as SOS response (ROS response, heavy metals resistant mechanisms, peptides), as well as Quorum network (acetoin cluster and aromatics biodegradation cluster). Characterization functional of AcoN-like as negative regulator protein from acetoin cluster in Acinetobacter spp. Strains

2019-07-16 | GSE120392 | GEO

Acinetobacter spp

Project description:Complete genome sequencing of carbapenem resistant Acinetobacter spp. clinical isolates

| PRJNA329669 | ENA

Acinetobacter baumannii

Project description:Carbapenem resistant Acinetobacter baumannii

| PRJNA494506 | ENA

Acinetobacter baumannii

Project description:Carbapenem resistant Acinetobacter baumannii

| PRJNA530638 | ENA

Acinetobacter baumannii

Project description:carbapenem-resistant Acinetobacter baumannii

| PRJNA1083246 | ENA

Acinetobacter baumannii

Project description:Carbapenem-resistant Acinetobacter baumannii from hosiptal

| PRJNA541386 | ENA

Acinetobacter baumannii

Project description:Carbapenem-resistant Acinetobacter baumannii in Serbia

| PRJNA1009670 | ENA

Acinetobacter baumannii response to cefiderocol challenge in human urine

Project description:Cefiderocol (CFDC) is a novel chlorocatechol-substituted siderophore approved to treat complicated urinary tract infections and for hospital-acquired and ventilator-acquired pneumonia. In previous work, human fluids, were shown to increase the minimum inhibitory concentration (MICs) of Acinetobacter baumannii against CFDC and reduce the expression of genes related to iron uptake systems, which could explain the need for higher concentrations of CFDC to exert inhibitory action. Herein, we analyzed the impact of human urine (HU), which contains low albumin concentrations, on the expression of iron-uptake related genes and MIC values of two carbapenem-resistant A. baumannii. Levels of resistance to CFDC were not modified by HU in strain AMA40 but were reduced in the case of strain AB5075. Testing other carbapenem-resistant A. baumannii isolates showed that the CFDC MICs were unmodified or reduced in the presence of HU. The expression of piuA, pirA, bauA, and bfnH determined by qRT-PCR was enhanced in both strains when HU was present in the culture medium. All four tested genes are involved in recognizing ferric siderophore complexes or internalization into the cell’s cytosol. In contrast, the effect of HU on genes associated with resistance to β-lactams, antibiotics commonly used to treat urinary tract infections caused by A. baumannii, was variable; the transcriptional analysis of pbp1, pbp3, blaOXA-51-like, blaADC, and blaNDM-1 showed significant variation. In summary, HU, probably due to the albumin and free iron content, does not adversely impact or slightly improves the activity of CFDC when tested against A. baumannii in urine in contrast to other human bodily fluids.

2022-06-01 | GSE201259 | GEO

Carbapenem-resistant Cambodian Acinetobacter baumannii

Project description:Carbapenem-resistant Cambodian Acinetobacter baumannii

| PRJEB61983 | ENA

Acinetobacter baumannii

Project description:Carbapenem-resistant Acinetobacter baumannii from hosiptal 1

| PRJNA541408 | ENA